The two main enzyme-deficient alleles of CYP2C19 are suspected to be associated with susceptibility to cancer, though several studies concerning CYP2C19 polymorphism and cancer susceptibility among various populations have reported inconsistent results [23-26]. This evidence concerns the gene CYP2C19 and cancer.